Acute Decompensated Heart Failure Forecast in 12 Major Markets 2017-2027 by Gender & 5 Year Age Cohort

Dublin, Jan. 11, 2018 -- The "Acute Decompensated Heart Failure Forecast in 12 Major Markets 2017-2027" report has been added to Research and Markets' offering.

Acute decompensated heart failure (ADHF), a sub-set of chronic heart failure (CHF), is a life-threatening episode during which the heart is not able to supply sufficient blood flow to the body. This requires urgent medical attention. The condition is divided into two subtypes: ADHF with reduced (ADHF-REF) and preserved (ADHF-PEF) ejection fraction. HF is characterized by dyspnoea at rest or on exertion and worsening fluid retention, apparent as lung congestion and/or swollen ankles and legs.

This report provides the current prevalent population for ADHF across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Japan, China, Russia, Brazil, India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight, ADHF-REF and ADHF-PEF patients have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot. Moreover, a forecast of ADHF patient populations demonstrating main comorbidities has been included.

Main co-morbidities for ADHF include:

• Diabetes
• COPD
• Anaemia
• Atrial fibrillation
• Coronary artery disease
  

Reasons to Buy:

• Able to quantify patient populations in global ADHF market to target the development of future products, pricing strategies and launch plans
• Gain further insight into the prevalence of the subdivided types of ADHF and identify patient segments with high potential
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries
• Provide a level of understanding on the impact from specific co-morbid conditions on ADHF prevalent population
• Identify sub-populations within ADHF which require treatment
• Gain an understanding of the specific markets that have the largest number of ADHF patients

Key Topics Covered:

1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Comorbid Conditions / Features Associated With the Disease
8. Methodology for Quantification of Patient Numbers
9. Top-Line Prevalence for Acute Decompensated Heart Failure
10. Acute Decompensated Heart Failure With Reduced Ejection Fraction
11. Comorbid Conditions of Adhf-Ref Patients
12. Acute Decompensated Heart Failure With Preserved Ejection Fraction
13. Comorbid Conditions of Adhf-Pef Patients
14. Abbreviations Used in the Report
15. Other Publications
16. Online Patient-Based Databases
17. Patient-Based Offering
18. Online Pricing Data & Platforms
19. References
20. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/5g8lnm/acute?w=12

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Cardiology